Our Team

Tal is Executive Chairman of the Board at Averna Therapeutics and a partner on the Private Equity team at OrbiMed, which he joined in 2021. He recently served as Chief Medical Officer at Moderna, where he led the development of the company’s COVID-19 vaccine and other key programs. He has also held senior drug development roles at leading pharmaceutical companies, including Sanofi and GlaxoSmithKline.

He received his MD and PhD from Ben-Gurion University and conducted postdoctoral research at the US National Institutes of Health.